Congressional Bill Offers Labs PAMA Pricing Relief
Legislation introduced last week would require the use of a more reliable representative sample to determine lab test reimbursement rates.
PAMA Hasn’t Reduced Part B Lab Test Costs
For the third straight year since the PAMA pricing system has been in place, overall year-over-year spending on lab tests increased in FY 2020.
Three Key Changes Your Lab Staff Need to Know About
CMS recently announced some important changes affecting PAMA price reporting, along with a list of 17 new PLA codes that will be recognized.
Already a member? Log in here
COVID-19 Testing Drives Increase in Part B Medicare Lab Spending
Here’s a look at the key takeaways from the Dec. 30 OIG report on Medicare Part B spending on lab testing.
Already a member? Log in here
Congress Acts to Delay 2022 PAMA Price Cuts at the Eleventh Hour
...
Already a member? Log in here